The mode of death in implantable cardioverter-defibrillator and cardiac resynchronization therapy with defibrillator patients: Results from routine clinical practice

Heart Rhythm

Volumn 9, Issue 10, 2012, Pages 1605-1612

  Thijssen, Joep ^a   Van Rees, Johannes B ^a   Venlet, Jeroen ^a   Borleffs, C Jan Willem ^a   Höke, Ulas ^a   Putter, Hein ^a   Van Der Velde, Enno T ^a   Van Erven, Lieselot ^a   Schalij, Martin J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cardiac resynchronization therapy with defibrillator; Implantable cardioverter defibrillator; Mode of death; Mortality; Sudden cardiac death

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SOTALOL;

ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CAUSE OF DEATH; CLINICAL PRACTICE; DEFIBRILLATOR; FOLLOW UP; HEART DEATH; HEART FAILURE; MORTALITY; NETHERLANDS; PRIMARY PREVENTION; PRIORITY JOURNAL; PROGNOSIS; SECONDARY PREVENTION;

AGED; ANALYSIS OF VARIANCE; CAUSE OF DEATH; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PRIMARY PREVENTION; RISK FACTORS; SECONDARY PREVENTION;

EID: 84866737540     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2012.04.021     Document Type: Article

References (34)

1. R.J. Myerburg, K.M. Kessler, A. Castellanos Sudden cardiac death: epidemiology, transient risk, and intervention assessment Ann Intern Med 119 1993 1187 1197
2. A.J. Moss, W.J. Hall, D.S. Cannom Multicenter Automatic Defibrillator Implantation Trial Investigators Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia N Engl J Med 335 1996 1933 1940
3. A.J. Moss, W. Zareba, W.J. Hall Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877 883
4. K.H. Kuck, R. Cappato, J. Siebels Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH) Circulation 102 2000 748 754
5. A. Kadish, A. Dyer, J.P. Daubert Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy N Engl J Med 350 2004 2151 2158
6. S.J. Connolly, M. Gent, R.S. Roberts Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone Circulation 101 2000 1297 1302
7. The antiarrhythmics versus implantable defibrillators (AVID) investigators Causes of death in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial J Am Coll Cardiol 34 1999 1552 1559
8. G.H. Bardy, K.L. Lee, D.B. Mark Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237
9. A.E. Epstein, J.P. DiMarco, K.A. Ellenbogen ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons Circulation 117 2008 e350 e408
10. J. Thijssen, C.J. Borleffs, J.B. van Rees Implantable cardioverter-defibrillator longevity under clinical circumstances: an analysis according to device type, generation, and manufacturer Heart Rhythm 9 2012 513 519
11. D.L. Packer, J.M. Prutkin, A.S. Hellkamp Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial Circulation 120 2009 2170 2176
12. K. Dickstein, A. Cohen-Solal, G. Filippatos ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur Heart J 29 2008 2388 2442
13. K. Dickstein, P.E. Vardas, A. Auricchio 2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association Eur Heart J 31 2010 2677 2687
14. G. Gregoratos, J. Abrams, A.E. Epstein ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines) Circulation 106 2002 2145 2161
15. S.G. Priori, E. Aliot, C. Blomstrom-Lundqvist Update of the guidelines on sudden cardiac death of the European Society of Cardiology Eur Heart J 24 2003 13 15
16. S.A. Strickberger, J. Conti, E.G. Daoud Patient selection for cardiac resynchronization therapy: from the Council on Clinical Cardiology Subcommittee on Electrocardiography and Arrhythmias and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the Heart Rhythm Society Circulation 111 2005 2146 2150
17. D.P. Zipes, A.J. Camm, M. Borggrefe ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Circulation 114 2006 e385 e484
18. L.E. Hinkle Jr, H.T. Thaler Clinical classification of cardiac deaths Circulation 65 1982 457 464
19. L. Scrucca, A. Santucci, F. Aversa Competing risk analysis using R: an easy guide for clinicians Bone Marrow Transplant 40 2007 381 387
20. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators N Engl J Med 337 1997 1576 1583
21. A.E. Buxton, K.L. Lee, J.D. Fisher Multicenter Unsustained Tachycardia Trial Investigators A randomized study of the prevention of sudden death in patients with coronary artery disease N Engl J Med 341 1999 1882 1890
22. J.T. Bigger Jr Coronary Artery Bypass Graft (CABG) Patch Trial Investigators Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery N Engl J Med 337 1997 1569 1575
23. J.A. Ezekowitz, P.W. Armstrong, F.A. McAlister Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials Ann Intern Med 138 2003 445 452
24. S.A. Strickberger, J.D. Hummel, T.G. Bartlett Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia - AMIOVIRT J Am Coll Cardiol 41 2003 1707 1712
25. M.R. Bristow, L.A. Saxon, J. Boehmer Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure N Engl J Med 350 2004 2140 2150
26. J.G. Cleland, J.C. Daubert, E. Erdmann The effect of cardiac resynchronization on morbidity and mortality in heart failure N Engl J Med 352 2005 1539 1549
27. A.J. Moss, W.J. Hall, D.S. Cannom Cardiac-resynchronization therapy for the prevention of heart-failure events N Engl J Med 361 2009 1329 1338
28. J.E. Poole, G.W. Johnson, A.S. Hellkamp Prognostic importance of defibrillator shocks in patients with heart failure N Engl J Med 359 2008 1009 1017
29. G.H. van Welsenes, J.B. van Rees, C.J. Borleffs Long-term follow-up of primary and secondary prevention implantable cardioverter defibrillator patients Europace 13 2011 389 394
30. L. Bode-Schnurbus, D. Bocker, M. Block QRS duration: a simple marker for predicting cardiac mortality in ICD patients with heart failure Heart 89 2003 1157 1162
31. H. Greenberg, R.B. Case, A.J. Moss Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II) J Am Coll Cardiol 43 2004 1459 1465
32. G.Z. Duray, J. Schmitt, S. Richter Arrhythmic death in implantable cardioverter defibrillator patients: a long-term study over a 10 year implantation period Europace 11 2009 1462 1468
33. L.B. Mitchell, E.A. Pineda, J.L. Titus Sudden death in patients with implantable cardioverter defibrillators: the importance of post-shock electromechanical dissociation J Am Coll Cardiol 39 2002 1323 1328
34. J.T. Bigger Jr, W. Whang, J.N. Rottman Mechanisms of death in the CABG Patch trial: a randomized trial of implantable cardiac defibrillator prophylaxis in patients at high risk of death after coronary artery bypass graft surgery Circulation 99 1999 1416 1421